Dabigatran

DB14726ApprovedInvestigationalSmall moleculeAntithrombins

Dabigatran is the active form of the orally bioavailable prodrug dabigatran etexilate.

Chemical structure of Dabigatran
Mechanism
Curator reviewed
Formula / weight
C25H25N7O3 · 471.521 g/mol (avg)
Code names
BIBR-953 · BIBR-953-ZW

Resolves to

Compound
UNIII0VM4M70GCCAS211914-51-1ChEMBLCHEMBL48361ChEBI70752KEGGD09707
Clinical / RWD
RxNorm1546356
Structure
InChIKeyYBSJFWOBGCMAKL-UHFFFAOYSA-NSMILESCN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(=C2)C(=O)N(CCC(O)=O)C1=NC=CC=C1
Targets
P00734F2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
642Drug interactionsStructured to mechanism, not free text
Sign in
166Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dabigatran, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In